Finally, we have investigated the hypothesis that reduction in MIAT expression levels enhances the response of breast cancer cells to cell death-inducing stimuli, including chemotherapeutic drugs and ultraviolet-C (UV-C). Here, MIAT is linked to breast carcinoma.